Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Colorectal Neoplasms 48Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Non-Small-Cell Lung 15Neoplasms 11Head and Neck Neoplasms 9Neoplasm Metastasis 8Lung Neoplasms 8Pancreatic Neoplasms 7Colonic Neoplasms 7Carcinoma, Squamous Cell 7Solid Tumors 5Rectal Neoplasms 4Ovarian Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Endometrial Neoplasms 3Colorectal Cancer Metastatic 3Carcinoma 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Recurrence 2Oropharyngeal Neoplasms 2Melanoma 2Locally Recurrent Rectal Cancer 2Carcinoma, Pancreatic Ductal 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1

Interventions

Injections 12pembrolizumab 7toripalimab 6tislelizumab 5Oxaliplatin 3Gemcitabine 3Cisplatin 3Carboplatin 3trastuzumab deruxtecan 2spartalizumab 2lenvatinib 2atezolizumab 2Paclitaxel 2Nivolumab 2Immune Checkpoint Inhibitors 2Fulvestrant 2Fluorouracil 2Docetaxel 2Cyclophosphamide 2Cetuximab 2Bevacizumab 2Albumin-Bound Paclitaxel 2zimberelimab 1penpulimab 1olaparib 1niraparib 1nedaplatin 1fludarabine phosphate 1fludarabine 1enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumor × Cetuximab × Clear all
NCT06241456 2025-12-09

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

Fate Therapeutics

Phase 1 Recruiting
351 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06332170 2024-07-18

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

Hansoh BioMedical R&D Company

Phase 1 Recruiting
610 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡